Product Information

TEGRETOL XR 100 MG TABLET is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $1.6239 per EA under NDC 00078051005. Its NADAC has been published 657 times since Nov 28, 2013.

The High Outlier badge above means this manufacturer's average price in the carbamazepine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

TEGRETOL XR 100 MG TABLET

carbamazepine
$1.6239per EA
High Outlier

Strength

100 mg/1

NDC

00078051005

Classification

Brand

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

CARBAMAZEPINE

Approval Type

New Drug (NDA)

FDA Application

NDA020234

On Market Since

3/25/1996

Pharmacological Classes

Cytochrome P450 1A2 Inducers
Cytochrome P450 2B6 Inducers
Cytochrome P450 2C19 Inducers
Cytochrome P450 2C9 Inducers
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity
Mood Stabilizer

Price Statistics

The NADAC for TEGRETOL XR 100 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 148.0%. The table below summarizes its recorded NADAC range and movement.

Current price$1.6239 per EA
All-time high$1.6345 (May 13, 2026)
All-time low$0.6461 (Dec 18, 2013)
52-week high$1.6345
52-week low$1.5862
Median price$1.2967
Average price$1.2520
Largest weekly change+14.9% (Jan 15, 2014)
Weeks tracked657
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+0.0%

3M

-0.6%

6M

+2.3%

1Y

+2.1%

3Y

+8.7%

5Y

+23.9%

All

+148.0%

Generic Alternatives

The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 86% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TEGRETOL XR 100 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TEGRETOL XR 100 MG TABLET, manufactured by Novartis Pharmaceuticals Corporation, is $1.6239 per EA (NDC 00078051005), effective Jun 24, 2026.

How has the price of TEGRETOL XR 100 MG TABLET changed over time?

Over the history we have for it, the NADAC for TEGRETOL XR 100 MG TABLET has risen 148.0%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for TEGRETOL XR 100 MG TABLET?

Since Nov 28, 2013, the NADAC for TEGRETOL XR 100 MG TABLET has ranged from a low of $0.6461 (Dec 18, 2013) to a high of $1.6345 (May 13, 2026), with a median of $1.2967 per EA.

Are there cheaper alternatives to TEGRETOL XR 100 MG TABLET?

Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, CARBAMAZEPINE ER 100 MG TABLET, is $0.2239 per EA — about 86% below TEGRETOL XR 100 MG TABLET.

Who manufactures TEGRETOL XR 100 MG TABLET?

TEGRETOL XR 100 MG TABLET (NDC 00078051005) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.